Jacobs Marni B, Klonoff-Cohen Hillary, Garzo V Gabriel
Department of Biostatistics and Study Methodology, Children's Research Institute, Children's National Health System, Washington, DC 20010, USA.
Department of Kinesiology and Community Health, College of Applied Health Sciences, University of Illinois at Urbana-Champaign, Champaign, IL 61820, USA.
J Hum Reprod Sci. 2018 Jan-Mar;11(1):45-51. doi: 10.4103/jhrs.JHRS_136_17.
When comparing success rates between treatments, it is more appropriate to structure analyses in terms of equivalence rather than traditional analyses that assess differences. Unfortunately, no studies of elective single blastocyst transfer (eSBT) have been conducted in this manner.
The objective of this study was to assess clinical equivalence of fertilization success rates among patients undergoing eSBT.
A historical prospective study was conducted at a private fertility center.
Medical records were reviewed to identify patients eligible for eSBT. Equivalency of success rates, defined as no more than a 10% difference based on 95% confidence intervals (CIs), was compared between eSBT ( = 125) and eDBT ( = 213) groups.
Using traditional analysis techniques, no differences in pregnancy or live-birth rates were seen (eSBT: 84.6% vs. eDBT: 84.5%, = 0.99; eSBT: 65.3% vs. eDBT: 72.3%, = 0.23). The 95% CI around the difference in pregnancy rates ranged from -7.9 to 8.1, suggesting clinically equivalent pregnancy rates. Clinical equivalence was not established for live-births (95% CI = -18.5-4.5).
Findings suggest comparable pregnancy rates can be achieved in a clinical setting when utilizing eSBT in good-prognosis patients. Although live-birth rate equivalence was not demonstrated, it is thought the additional complications associated with multiple gestations outweigh the potentially higher live-birth rate. The present study highlights the importance of utilizing equivalence analyses when making statements regarding the similarity of two treatments in reproductive health, rather than relying on superiority analyses alone.
在比较不同治疗方法的成功率时,采用等效性分析比传统的差异评估分析更为合适。遗憾的是,尚未有研究以这种方式对选择性单囊胚移植(eSBT)进行研究。
本研究的目的是评估接受eSBT治疗的患者受精成功率的临床等效性。
在一家私立生育中心进行了一项历史性前瞻性研究。
回顾医疗记录以确定符合eSBT条件的患者。比较了eSBT组(n = 125)和eDBT组(n = 213)成功率的等效性,定义为基于95%置信区间(CI)差异不超过10%。
使用传统分析技术,未观察到妊娠率或活产率的差异(eSBT:84.6% vs. eDBT:84.5%,P = 0.99;eSBT:65.3% vs. eDBT:72.3%,P = 0.23)。妊娠率差异的95%CI范围为-7.9至8.1,表明临床妊娠率相当。活产率未确立临床等效性(95%CI = -18.5 - 4.5)。
研究结果表明,在临床环境中,对预后良好的患者采用eSBT可获得相当的妊娠率。虽然未证明活产率等效,但认为多胎妊娠相关的额外并发症超过了可能更高的活产率。本研究强调了在生殖健康领域对两种治疗方法的相似性进行陈述时,采用等效性分析的重要性,而不是仅依赖于优效性分析。